There have been reports of skin rash developing in patients with COVID-19 on favipiravir therapy, including a recent report in this journal. We report a patient who developed a maculopapular skin rash while taking favipiravir. © 2022 British Association of Dermatologists.
Won Sriwijitalai, Viroj Wiwanitkit. COVID-19 and favipiravir induce cutaneous adverse reactions: a difficulty in clinical dermatology practice. Clinical and experimental dermatology. 2022 Jul;47(7):1382-1383
PMID: 35357031
View Full Text